FindMyKOL

Top experts by indication / Oncology

Most active experts in Hepatobiliary Cancer

2026 edition, data as of October 26, 2026

361 key opinion leaders in the directory are tagged to Hepatobiliary Cancer. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.

Most registered trials

Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 235 of the 361 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.

#Experttrials
1Tim GretenNational Institutes of Health, MD13 trials
2Andrew ZhuMassachusetts General Hospital, MA11 trials
3David HsiehTX7 trials
4Vaibhav SahaiUniversity of Michigan, MI7 trials
5Richard KimMoffitt Cancer Center, FL7 trials
6Amit SingalUT Southwestern Medical Center, TX6 trials
7Daniel ChangMI5 trials
8Mehmet AkceAL5 trials
9Richard FinnUniversity of California, Los Angeles, CA5 trials
10Daneng LiCity of Hope, CA5 trials
11Renuka IyerRoswell Park Comprehensive Cancer Center, NY5 trials
12Mitesh BoradMayo Clinic, AZ5 trials
13Devalingam MahalingamNorthwestern University Feinberg School of Medicine, IL5 trials
14Aiwu HeColumbia University in the City of New York, NY5 trials
15Steven AlbertsMayo Clinic, MN5 trials
16David SteffinBaylor College of Medicine, TX4 trials
17Yehuda PattUniversity of New Mexico, NM4 trials
18Melanie ThomasSC4 trials
19Apostolia TsimberidouThe University of Texas MD Anderson Cancer Center, TX4 trials
20Lynn FeunUniversity of Miami, FL4 trials
21Anthony El-KhoueiryUSC Norris Comprehensive Cancer Center, CA4 trials
22Theodore HongMassachusetts General Hospital, MA4 trials
23Nilofer AzadJohns Hopkins University School of Medicine, MD4 trials
24Robert MartinUniversity of Louisville School of Medicine, KY4 trials
25Amit MahipalUniversity Hospitals Cleveland Medical Center, MN4 trials

Most cited

Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 61 of the 361 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.

#Expertcitations
1Razelle KurzrockMedical College of Wisconsin, WI88,610 citations
2Richard FinnUniversity of California, Los Angeles, CA83,997 citations
3Andrew ZhuMassachusetts General Hospital, MA79,839 citations
4Al BensonNorthwestern University Feinberg School of Medicine, IL74,238 citations
5Mitesh BoradMayo Clinic, AZ60,996 citations
6Scott KopetzThe University of Texas MD Anderson Cancer Center, TX59,091 citations
7Tim GretenNational Institutes of Health, MD54,882 citations
8Amit SingalUT Southwestern Medical Center, TX48,718 citations
9Alan VenookUniversity of California, San Francisco, CA43,039 citations
10Jordan BerlinVanderbilt University Medical Center, TN40,633 citations
11Hedy KindlerUniversity of Chicago, IL39,455 citations
12Nancy KemenyMemorial Sloan Kettering Cancer Center, NY37,022 citations
13Jennifer TemelMassachusetts General Hospital, MA36,476 citations
14Patricia LorussoYale School of Medicine, MI34,992 citations
15Andrea CercekMemorial Sloan Kettering Cancer Center, NY33,805 citations
16Afshin DowlatiUniversity Hospitals Seidman Cancer Center, OH32,821 citations
17Vivek SubbiahStanford University School of Medicine, CA32,217 citations
18Nilofer AzadJohns Hopkins University School of Medicine, MD30,922 citations
19Albert KoongThe University of Texas MD Anderson Cancer Center, TX29,925 citations
20Alexander SpiraVirginia Cancer Specialists, VA29,600 citations
21Steven AlbertsMayo Clinic, MN24,526 citations
22Apostolia TsimberidouThe University of Texas MD Anderson Cancer Center, TX24,111 citations
23Theodore HongMassachusetts General Hospital, MA23,847 citations
24Milind JavleThe University of Texas MD Anderson Cancer Center, TX22,987 citations
25Anthony El-KhoueiryUSC Norris Comprehensive Cancer Center, CA22,591 citations

Most NIH awards

NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 46 of the 361 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.

#Expertawards
1William CarsonThe Ohio State University, OH19 awards
2Scott KopetzThe University of Texas MD Anderson Cancer Center, TX13 awards
3Jennifer TemelMassachusetts General Hospital, MA10 awards
4Amit SingalUT Southwestern Medical Center, TX10 awards
5James EconomouCA9 awards
6Al BensonNorthwestern University Feinberg School of Medicine, IL8 awards
7Jordan BerlinVanderbilt University Medical Center, TN8 awards
8Yoon KimIL7 awards
9Anthony ShieldsMI6 awards
10Afshin DowlatiUniversity Hospitals Seidman Cancer Center, OH6 awards
11Hedy KindlerUniversity of Chicago, IL6 awards
12Steven AlbertsMayo Clinic, MN6 awards
13Yun YenCA5 awards
14Anthony El-KhoueiryUSC Norris Comprehensive Cancer Center, CA5 awards
15Nilofer AzadJohns Hopkins University School of Medicine, MD5 awards
16Albert KoongThe University of Texas MD Anderson Cancer Center, TX4 awards
17Rachna ShroffUniversity of Arizona College of Medicine, AZ4 awards
18Andrea CercekMemorial Sloan Kettering Cancer Center, NY4 awards
19Patricia LorussoYale School of Medicine, MI4 awards
20Steven CohenPA3 awards
21Eugene KoayThe University of Texas MD Anderson Cancer Center, TX3 awards
22Theodore HongMassachusetts General Hospital, MA3 awards
23Mitesh BoradMayo Clinic, AZ3 awards
24Adam YoppUT Southwestern Medical Center, TX3 awards
25Alan VenookUniversity of California, San Francisco, CA3 awards

Most congress contributions

Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 29 of the 361 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: Congress abstracts, DOI-verified.

#Expertcontributions
1Anthony El-KhoueiryUSC Norris Comprehensive Cancer Center, CA275 contributions
2Patricia LorussoYale School of Medicine, MI272 contributions
3Theodore HongMassachusetts General Hospital, MA250 contributions
4Siqing FuThe University of Texas MD Anderson Cancer Center, TX241 contributions
5Milind JavleThe University of Texas MD Anderson Cancer Center, TX228 contributions
6Albert KoongThe University of Texas MD Anderson Cancer Center, TX221 contributions
7Jennifer TemelMassachusetts General Hospital, MA202 contributions
8Afshin DowlatiUniversity Hospitals Seidman Cancer Center, OH201 contributions
9Amit MahipalUniversity Hospitals Cleveland Medical Center, MN189 contributions
10Hedy KindlerUniversity of Chicago, IL163 contributions
11Al BensonNorthwestern University Feinberg School of Medicine, IL160 contributions
12Jordan BerlinVanderbilt University Medical Center, TN156 contributions
13Davendra SohalUniversity of Cincinnati, OH144 contributions
14Andrea CercekMemorial Sloan Kettering Cancer Center, NY142 contributions
15Richard KimMoffitt Cancer Center, FL141 contributions
16Steven AlbertsMayo Clinic, MN138 contributions
17Aiwu HeColumbia University in the City of New York, NY134 contributions
18Rachna ShroffUniversity of Arizona College of Medicine, AZ133 contributions
19Anwaar SaeedUniversity of Pittsburgh, KS123 contributions
20Nilofer AzadJohns Hopkins University School of Medicine, MD121 contributions
21Devalingam MahalingamNorthwestern University Feinberg School of Medicine, IL116 contributions
22Vaibhav SahaiUniversity of Michigan, MI108 contributions
23Tim GretenNational Institutes of Health, MD93 contributions
24Daneng LiCity of Hope, CA81 contributions
25Roxana DroncaMayo Clinic, FL70 contributions

Emerging

19 of the 361 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.

Alina AllenMayo Clinic, MN
Olivia AranhaWashington University School of Medicine in St. Louis, MO
Marina BarettiJohns Hopkins University School of Medicine, MD
Stephane ChampiatThe University of Texas MD Anderson Cancer Center, TX
Paul GaglioRutgers New Jersey Medical School, NJ
Phillip GarfinJazz Pharmaceuticals, CA
Spiros HiotisIcahn School of Medicine at Mount Sinai, NY
Theodore HongMassachusetts General Hospital, MA
Udai KammulaUniversity of Pittsburgh, PA
Theodore LawrenceUniversity of Michigan, MI
Heinz-Josef LenzUSC Norris Comprehensive Cancer Center, CA
Daniel NussbaumNC
Suzanne SchiffmanAllegheny Health Network, PA
Kevin SoaresMemorial Sloan Kettering Cancer Center, NY
Achuthan SourianarayananeMedical College of Wisconsin, WI
Corinne SummersSeattle Children's Hospital, WA
Apostolia TsimberidouThe University of Texas MD Anderson Cancer Center, TX
Jennifer WoHarvard University, MA
Janghee WooWA

How these tables are computed

The cohort is every profile in the directory tagged to Hepatobiliary Cancer, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.

Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.

The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.

What is deliberately absent

Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.

Filter, sort and open every Hepatobiliary Cancer profile in the directory